A clinical approach to chronic dyspnea

Clinical Pulmonary Medicine

Volumn 13, Issue 3, 2006, Pages 149-163

  Pratter, Melvin R ^a   Bartter, Thaddeus ^a   Akers, Stephen M ^a   Kass, Jonathan ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Bronchial provocation tests; Cardiopulmonary; Diagnosis; Differential; Dyspnea; Exercise; Respiratory function tests; Testing

Indexed keywords

ALGORITHM; ANAMNESIS; ANTERIOR HORN CELL DISEASE; ARTERIAL GAS; BREATHING MUSCLE; BRONCHOSCOPY; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DIAPHRAGM PARALYSIS; DIFFERENTIAL DIAGNOSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSPNEA; ELECTROMYOGRAPHY; ENDOCARDIUM; EXERCISE TEST; EXTRAPYRAMIDAL SYNDROME; FUNNEL CHEST; GASTROINTESTINAL ENDOSCOPY; GREAT BLOOD VESSEL; HEART CATHETERIZATION; HEART RIGHT VENTRICLE FAILURE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; KYPHOSIS; LARYNGOSCOPY; LOWER RESPIRATORY TRACT; LUNG ANGIOGRAPHY; LUNG FUNCTION TEST; LUNG PARENCHYMA; LUNG VENTILATION PERFUSION RATIO; MENTAL DISEASE; MUSCLE BIOPSY; MYOCARDIAL DISEASE; NERVE BIOPSY; NERVE CONDUCTION; NEUROMUSCULAR DISEASE; NEUROMUSCULAR JUNCTION DISORDER; NON INVASIVE PROCEDURE; OBESITY; PANIC; PERICARDIAL DISEASE; PHYSICAL EXAMINATION; PLEURA DISEASE; PLEURA EFFUSION; PREGNANCY; PRUNE BELLY SYNDROME; PULMONARY ARTERY DISEASE; PULMONARY HYPERTENSION; RADIOISOTOPE VENTRICULOGRAPHY; RESPIRATORY TRACT DISEASE; REVIEW; SCOLIOSIS; SPINAL CORD INJURY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THORAX RADIOGRAPHY; THORAX WALL; THROMBOEMBOLISM; TWO DIMENSIONAL ECHOCARDIOGRAPHY; UPPER RESPIRATORY TRACT OBSTRUCTION;

EID: 33646785400     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000218457.78185.5f     Document Type: Review

References (282)

1. Kroenke K, Arrington ME, Mangelsdorff AD. The prevalence of symptoms in medical outpatients and the adequacy of therapy. Arch Intern Med. 1990;150:1685-1689.
2. Kroenke K, Mangelsdorff AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med. 1989;86:262-266.
3. Mahler DA, Harver A, Lentine T, et al. Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care Med. 1996;154:1357-1363.
4. Di Pede C, Viegi G, Quackenboss JJ, et al. Respiratory symptoms and risk factors in an Arizona population sample of Anglo and Mexican-American whites. Chest. 1991;99:916-922.
5. DePaso WJ, Winterbauer RH, Lusk JA, et al. Chronic dyspnea unexplained by history, physical examination, chest roentgenogram, and spirometry. Analysis of a seven-year experience. Chest. 1991;100:1293-1299.
6. Pratter MR, Curley FJ, Dubois J, et al. Cause and evaluation of chronic dyspnea in a pulmonary disease clinic. Arch Intern Med. 1989;149:2277-2282.
7. Martinez FJ, Stanopoulos I, Acero R, et al. Graded comprehensive cardiopulmonary exercise testing in the evaluation of dyspnea unexplained by routine evaluation. Chest. 1994;105:168-174.
8. Au DH, Udris EM, Fan VS, et al. Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction. Chest. 2003;123:1964-1969.
9. Sin DD, Jones RL, Man SF. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med. 2002;162:1477-1481.
10. Manning HL, Schwartzstein RM. Pathophysiology of dyspnea. N Engl J Med. 1995;333:1547-1553.
11. Altose M, Cherniack N, Fishman AP. Respiratory sensations and dyspnea. J Appl Physiol. 1985;58:1051-1054.
12. Tobin MJ. Dyspnea. Pathophysiologic basis, clinical presentation, and management. Arch Intern Med. 1990;150:1604-1613.
13. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med. 1999;159:321-340.
14. Peiffer C, Poline JB, Thivard L, et al. Neural substrates for the perception of acutely induced dyspnea. Am J Respir Crit Care Med. 2001;163:951-957.
15. Simon PM, Schwartzstein RM, Weiss JW, et al. Distinguishable sensations of breathlessness induced in normal volunteers. Am Rev Respir Dis. 1989;140:1021-1027.
16. Simon PM, Schwartzstein RM, Weiss JW, et al. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis. 1990;142:1009-1014.
17. Mahler DA, Rosiello RA, Harver A, et al. Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. Am Rev Respir Dis. 1987;135:1229-1233.
18. Mahler DA, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992;145:467-470.
19. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med. 1999;159:321-340.
20. Morris MJ, Grbach VX, Deal LE, et al. Evaluation of exertional dyspnea in the active duty patient: the diagnostic approach and the utility of clinical testing. Mil Med. 2002;167:281-288.
21. Vincken W, Elleker MG, Cosio MG. Determinants of respiratory muscle weakness in stable chronic neuromuscular disorders. Am J Med. 1987;82:53-58.
22. Silver JR, Moulton A. The physiological and pathological sequelae of paralysis of the intercostal and abdominal muscles in tetraplegic patients. Paraplegia. 1969;7:131-141.
23. Ledsome JR, Sharp JM. Pulmonary function in acute cervical cord injury. Am Rev Respir Dis. 1981;124:41-44.
24. Scanlon PD, Loring SH, Pichurko BM, et al. Respiratory mechanics in acute quadriplegia. Lung and chest wall compliance and dimensional changes during respiratory maneuvers. Am Rev Respir Dis. 1989;139:615-620.
25. Olgiati R, Jacquet J, Di Prampero PE. Energy cost of walking and exertional dyspnea in multiple sclerosis. Am Rev Respir Dis. 1986;134:1005-1010.
26. Silver JR, Lehr RP. Dyspnoea during generalised spasms in tetraplegic patients. J Neurol Neurosurg Psychiatry. 1981;44:842-845.
27. DeLuca RV, Grimm DR, Lesser M, et al. Effects of a beta2-agonist on airway hyperreactivity in subjects with cervical spinal cord injury. Chest. 1999;115:1533-1538.
28. Nightingale S, Bates D, Bateman DE, et al. Enigmatic dyspnoea: an unusual presentation of motor-neurone disease. Lancet. 1982;1:933-935.
29. Fromm GB, Wisdom PJ, Block AJ. Amyotrophic lateral sclerosis presenting with respiratory failure. Diaphragmatic paralysis and dependence on mechanical ventilation in two patients. Chest. 1977;71:612-614.
30. Hill R, Martin J, Hakim A. Acute respiratory failure in motor neuron disease. Arch Neurol. 1983;40:30-32.
31. Black LF, Hyatt RE. Maximal static respiratory pressures in generalized neuromuscular disease. Am Rev Respir Dis. 1971;103:641-650.
32. Knobil K, Becker FS, Harper P, et al. Dyspnea in a patient years after severe poliomyelitis. The role of cardiopulmonary exercise testing. Chest. 1994;105:777-781.
33. Chan CK, Mohsenin V, Loke J, et al. Diaphragmatic dysfunction in siblings with hereditary motor and sensory neuropathy (Charcot-Marie-Tooth disease). Chest. 1987;91:567-570.
34. Schmalstieg EJ, Peters BH, Schochet SS, et al. Neuropathy presenting as prolonged dyspnea. Case report and review of literature. Arch Neurol. 1977;34:473-476.
35. Mokhlesi B, Jain M. Pulmonary manifestations of POEMS syndrome: case report and literature review. Chest. 1999;115:1740-1742.
36. Thomas NE, Passamonte PM, Sunderrajan EV, et al. Bilateral diaphragmatic paralysis as a possible paraneoplastic syndrome from renal cell carcinoma. Am Rev Respir Dis. 1984;129:507-509.
37. Ciccolella DE, Daly BD, Celli BR. Improved diaphragmatic function after surgical plication for unilateral diaphragmatic paralysis. Am Rev Respir Dis. 1992;146:797-799.
38. Laroche CM, Carroll N, Moxham J, et al. Clinical significance of severe isolated diaphragm weakness. Am Rev Respir Dis. 1988;138:862-866.
39. Mulvey DA, Aquilina RJ, Elliott MW, et al. Diaphragmatic dysfunction in neuralgic amyotrophy: an electrophysiologic evaluation of 16 patients presenting with dyspnea. Am Rev Respir Dis. 1993;147:66-71.
40. Hart N, Nickol AH, Cramer D, et al. Effect of severe isolated unilateral and bilateral diaphragm weakness on exercise performance. Am J Respir Crit Care Med. 2002;165:1265-1270.
41. Kreitzer SM, Feldman NT, Saunders NA, et al. Bilateral diaphragmatic paralysis with hypercapnic respiratory failure. A physiologic assessment. Am J Med. 1978;65:89-95.
42. Kohorst WR, Schonfeld SA, Altman M. Bilateral diaphragmatic paralysis following topical cardiac hypothermia. Chest. 1984;85:65-68.
43. Chandler KW, Rozas CJ, Kory RC, et al. Bilateral diaphragmatic paralysis complicating local cardiac hypothermia during open heart surgery. Am J Med. 1984;77:243-249.
44. Hardy K, Herry I, Attali V, et al. Bilateral phrenic paralysis in a patient with systemic lupus erythematosus. Chest. 2001;119:1274-1277.
45. Wheeler WE, Rubis LJ, Jones CW, et al. Etiology and prevention of topical cardiac hypothermia-induced phrenic nerve injury and left lower lobe atelectasis during cardiac surgery. Chest. 1985;88:680-683.
46. Schram DJ, Vosik W, Cantral D. Diaphragmatic paralysis following cervical chiropractic manipulation: case report and review. Chest. 2001;119:638-640.
47. Mier-Jedrzejowicz A, Green M. Respiratory muscle weakness associated with cerebellar atrophy. Am Rev Respir Dis. 1988;137:673-677.
48. Driver AG, Blackburn BB, Marcuard SP, et al. Bilateral diaphragm paralysis treated with cuirass ventilation. Chest. 1987;92:683-685.
49. Mier-Jedrzejowicz AK, Brophy C, Green M. Respiratory muscle function in myasthenia gravis. Am Rev Respir Dis. 1988;138:867-873.
50. Schmidt-Nowara WW, Samet JM, Rosario PA. Early and late pulmonary complications of botulism. Arch Intern Med. 1983;143:451-456.
51. Wilcox PG, Morrison NJ, Pardy RL. Recovery of the ventilatory and upper airway muscles and exercise performance after type A botulism. Chest. 1990;98:620-626.
52. Wilcox P, Andolfatto G, Fairbarn MS, et al. Long-term follow-up of symptoms, pulmonary function, respiratory muscle strength, and exercise performance after botulism. Am Rev Respir Dis. 1989;139:157-163.
53. Braun NM, Arora NS, Rochester DF. Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies. Thorax. 1983;38:616-623.
54. Lanini B, Misuri G, Gigliotti F, et al. Perception of dyspnea in patients with neuromuscular disease. Chest. 2001;120:402-408.
55. Bach JR, Alba AS. Management of chronic alveolar hypoventilation by nasal ventilation. Chest. 1990;97:52-57.
56. Wilcox PG, Stein HB, Clarke SD, et al. Phrenic nerve function in patients with diaphragmatic weakness and systemic lupus erythematosus. Chest. 1988;93:352-358.
57. Martens J, Demedts M, Vanmeenen MT, et al. Respiratory muscle dysfunction in systemic lupus erythematosus. Chest. 1983;84:170-175.
58. Thompson PJ, Dhillon DP, Ledingham J, et al. Shrinking lungs, diaphragmatic dysfunction, and systemic lupus erythematosus. Am Rev Respir Dis. 1985;132:926-928.
59. Schiavi EA, Roncoroni AJ, Puy RJ. Isolated bilateral diaphragmatic paresis with interstitial lung disease. An unusual presentation of dermatomyositis. Am Rev Respir Dis. 1984;129:337-339.
60. Chausow AM, Kane T, Levinson D, et al. Reversible hypercapnic respiratory insufficiency in scleroderma caused by respiratory muscle weakness. Am Rev Respir Dis. 1984;130:142-144.
61. Fitting JW, Leuenberger P. Procainamide for dyspnea in myotonic dystrophy. Am Rev Respir Dis. 1989;140:1442-1445.
62. Flaherty KR, Wald J, Weisman IM, et al. Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med. 2001;164:425-432.
63. Schwartz M, Vissing J. Paternal inheritance of mitochondrial DNA. N Engl J Med. 2002;347:576-580.
64. Clay AS, Behnia M, Brown KK. Mitochondrial disease: a pulmonary and critical-care medicine perspective. Chest. 2001;120:634-648.
65. Hooper RG, Thomas AR, Kearl RA. Mitochondrial enzyme deficiency causing exercise limitation in normal-appearing adults. Chest. 1995;107:317-322.
66. Nugent CA, Harris W, Cohn J, et al. Dyspnea as a symptom in Parkinson's syndrome. Am Rev Tuberc. 1958;78:682-691.
67. Vincken WG, Gauthier SG, Dollfuss RE, et al. Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. N Engl J Med. 1984;311:438-442.
68. Weiner WJ, Goetz CG, Nausieda PA, et al. Respiratory dyskinesias: extrapyramidal dysfunction and dyspnea. Ann Intern Med. 1978;88:327-331.
69. Moisan TC, Chandrasekhar AJ, Sharp JT. Asynchronous breathing: a possible etiology for dyspnea in a patient with normal lungs. Chest. 1979;75:624-626.
70. Ivanovich M, Glantz R, Bone RC, et al. Respiratory dyskinesia presenting as acute respiratory distress. Chest. 1993;103:314-316.
71. Weiner P, Inzelberg R, Davidovich A, et al. Respiratory muscle performance and the perception of dyspnea in Parkinson's disease. Can J Neurol Sci. 2002;29:68-72.
72. Phillips JR, Eldridge FL. Respiratory myoclonus (Leeuwenhoek's disease). N Engl J Med. 1973;289:1390-1395.
73. Rich MW, Radwany SM. Respiratory dyskinesia. An underrecognized phenomenon. Chest. 1994;105:1826-1832.
74. Braun N, Abd A, Baer J, et al. Dyspnea in dystonia. A functional evaluation. Chest. 1995;107:1309-1316.
75. Tzelepis GE, McCool FD, Friedman JH, et al. Respiratory muscle dysfunction in Parkinson's disease. Am Rev Respir Dis. 1988;138:266-271.
76. Kafer ER. Idiopathic scoliosis. Gas exchange and the age dependence of arterial blood gases. J Clin Invest. 1976;58:825-833.
77. Bergofsky EH. Respiratory failure in disorders of the thoracic cage. Am Rev Respir Dis. 1979;119:643-669.
78. Hoeppner VH, Cockcroft DW, Dosman JA, et al. Nighttime ventilation improves respiratory failure in secondary kyphoscoliosis. Am Rev Respir Dis. 1984;129:240-243.
79. Lisboa C, Moreno R, Fava M, et al. Inspiratory muscle function in patients with severe kyphoscoliosis. Am Rev Respir Dis. 1985;132:48-52.
80. Castile RG, Staats BA, Westbrook PR. Symptomatic pectus deformities of the chest. Am Rev Respir Dis. 1982;126:564-568.
81. Morshuis W, Folgering H, Barentsz J, et al. Pulmonary function before surgery for pectus excavatum and at long-term follow-up. Chest. 1994;105:1646-1652.
82. Morshuis WJ, Folgering HT, Barentsz JO, et al. Exercise cardiorespiratory function before and one year after operation for pectus excavatum. J Thorac Cardiovasc Surg. 1994;107:1403-1409.
83. Beiser GD, Epstein SE, Stampfer M, et al. Impairment of cardiac function in patients with pectus excavatum, with improvement after operative correction. N Engl J Med. 1972;287:267-272.
84. Ewig JM, Griscom NT, Wohl ME. The effect of the absence of abdominal muscles on pulmonary function and exercise. Am J Respir Crit Care Med. 1996;153:1314-1321.
85. George L, Rehman SU, Khan FA. Diaphragmatic rupture: a complication of violent cough. Chest. 2000;117:1200-1201.
86. Estenne M, Yernault JC, De Troyer A. Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusions. Am J Med. 1983;74:813-819.
87. Light RW, Rogers JT, Moyers JP, et al. Prevalence and clinical course of pleural effusions at 30 days after coronary artery and cardiac surgery. Am J Respir Crit Care Med. 2002;166:1567-1571.
88. Wang JS, Tseng CH. Changes in pulmonary mechanics and gas exchange after thoracentesis on patients with inversion of a hemidiaphragm secondary to large pleural effusion. Chest. 1995;107:1610-1614.
89. Chernow B, Sahn SA. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med. 1977;63:695-702.
90. Pope AR, Joseph JH. Pleuroperitoneal shunt for pneumonectomy cavity malignant effusion. Chest. 1989;96:686-688.
91. Colp C, Reichel J, Park SS. Severe pleural restriction: the maximum static pulmonary recoil pressure as an aid in diagnosis. Chest. 1975;67:658-664.
92. Huang HC, Chang HY, Chen CW, et al. Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion for empyema. Chest. 1999;115:751-756.
93. LeMense GP, Strange C, Sahn SA. Empyema thoracis. Therapeutic management and outcome. Chest. 1995;107:1532-1537.
94. Inci I, Ozcelik C, Ulku R, et al. Intrapleural fibrinolytic treatment of traumatic clotted hemothorax. Chest. 1998;114:160-165.
95. Hunninghake GW, Fauci AS. Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis. 1979;119:471-503.
96. Miller A, Teirstein AS, Selikoff IJ. Ventilatory failure due to asbestos pleurisy. Am J Med. 1983;75:911-919.
97. Vincken WG, Darauay CM, Cosio MG. Reversibility of upper airway obstruction after levodopa therapy in Parkinson's disease. Chest. 1989;96:210-212.
98. Al Bazzaz F, Grillo H, Kazemi H. Response to exercise in upper airway obstruction. Am Rev Respir Dis. 1975;111:631-640.
99. Geffin B, Grillo HC, Cooper JD, et al. Stenosis following tracheostomy for respiratory care. JAMA. 1971;216:1984-1988.
100. Meysman M, Noppen M, Vincken W. Effect of posture on the flow-volume loop in two patients with euthyroid goiter. Chest. 1996;110:1615-1618.
101. Cormier Y, Kashima H, Summer W, et al. Upper airways obstruction with bilateral vocal cord paralysis. Chest. 1979;75:423-427.
102. Bolliger CT, Sopko J, Maurer P, et al. The flow-volume loop in bilateral vocal cord paralysis. Chest. 1993;104:1302-1304.
103. Vincken WG, Gauthier SG, Dollfuss RE, et al. Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. N Engl J Med. 1984;311:438-442.
104. Vincken W, Elleker G, Cosio MG. Detection of upper airway muscle involvement in neuromuscular disorders using the flow-volume loop. Chest. 1986;90:52-57.
105. Kryger M, Bode F, Antic R, et al. Diagnosis of obstruction of the upper and central airways. Am J Med. 1976;61:85-93.
106. Hunter JH, Stanford W, Smith JM, et al. Expiratory collapse of the trachea presenting as worsening asthma. Chest. 1993;104:633-635.
107. Gamsu G, Borson DB, Webb WR, et al. Structure and function in tracheal stenosis. Am Rev Respir Dis. 1980;121:519-531.
108. Irwin RS, Pratter MR, Holland PS, et al. Postnasal drip causes cough and is associated with reversible upper airway obstruction. Chest. 1984;85:346-352.
109. Das AK, Davanzo LD, Poiani GJ, et al. Variable extrathoracic airflow obstruction and chronic laryngotracheitis in Gulf War veterans. Chest. 1999;115:97-101.
110. Becker GL, Tenholder MF, Hunt KK. Obligate mouth breathing during exercise. Nasal and laryngeal sarcoidosis. Chest. 1990;98:756-757.
111. Christopher KL, Wood RP, Eckert RC, et al. Vocal-cord dysfunction presenting as asthma. N Engl J Med. 1983;308:1566-1570.
112. Couser JI Jr, Berman JS. Respiratory muscle fatigue from functional upper airway obstruction. Chest. 1989;96:689-690.
113. Pitchenik AE. Functional laryngeal obstruction relieved by panting. Chest. 1991;100:1465-1467.
114. Vlahakis NE, Patel AM, Maragos NE, et al. Diagnosis of vocal cord dysfunction: the utility of spirometry and plethysmography. Chest. 2002;122:2246-2249.
115. Morris MJ, Deal LE, Bean DR, et al. Vocal cord dysfunction in patients with exertional dyspnea. Chest. 1999;116:1676-1682.
116. Rundell KW, Spiering BA. Inspiratory stridor in elite athletes. Chest. 2003;123:468-474.
117. Burrows B. Differential diagnosis of chronic obstructive pulmonary disease. Chest. 1990;97(suppl):16S-18S.
118. Kinsman RA, Yaroush RA, Fernandez E, et al. Symptoms and experiences in chronic bronchitis and emphysema. Chest. 1983;83:755-761.
119. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis. 1993;148:1351-1357.
120. Killian KJ, Leblanc P, Martin DH, et al. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis. 1992;146:935-940.
121. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:770-777.
122. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256-1276.
123. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ. 1977;1:1645-1648.
124. Colp C, Park SS, Williams MH Jr. Emphysema with little airway obstruction. Am Rev Respir Dis. 1970;101:615-619.
125. Chin NK, Lim TK. A 39-year-old smoker with effort dyspnea, normal spirometry results, and low diffusing capacity. Chest. 1998;113:231-233.
126. Klein JS, Gamsu G, Webb WR, et al. High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity. Radiology. 1992;182:817-821.
127. Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2000;160:1683-1689.
128. Halbert RJ, Isonaka S, George D, et al. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003;123:1684-1692.
129. Feenstra TL, van Genugten ML, Hoogenveen RT, et al. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in The Netherlands. Am J Respir Crit Care Med. 2001;164:590-596.
130. Coultas DB, Mapel D, Gagnon R, et al. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med. 2001;164:372-377.
131. Birring SS, Brightling CE, Bradding P, et al. Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. Am J Respir Crit Care Med. 2002;166:1078-1083.
132. Enright PL, McClelland RL, Newman AB, et al. Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest. 1999;116:603-613.
133. Farr RS, Kopetzky MT, Spector SL, et al. Asthma without wheezing. Chest. 1973;63(suppl 68S).
134. Irwin RS, Pratter MR. The clinical value of pharmacologic bronchoprovocation challenge. Med Clin North Am. 1990;74:767-778.
135. Kang BC, Grizz V, Phillips B. Nonwheezing bronchial asthma diagnosed by methacholine challenge. Am J Med. 1990;88:675-677.
136. Pratter MR, Hingston DM, Irwin RS. Diagnosis of bronchial asthma by clinical evaluation. An unreliable method. Chest. 1983;84:42-47.
137. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165:277-304.
138. Green FH. Overview of pulmonary fibrosis. Chest. 2002;122(suppl):334S- 339S.
139. Raghu G, Mageto YN, Lockhart D, et al. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest. 1999;116:1168-1174.
140. Raghu G. Interstitial lung disease: a diagnostic approach. Are CT scan and lung biopsy indicated in every patient? Am J Respir Crit Care Med. 1995;151:909-914.
141. Mahler DA, Harver A, Rosiello R, et al. Measurement of respiratory sensation in interstitial lung disease. Evaluation of clinical dyspnea ratings and magnitude scaling. Chest. 1989;96:767-771.
142. Watters LC, King TE, Schwarz MI, et al. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1986;133:97-103.
143. Brack T, Jubran A, Tobin MJ. Dyspnea and decreased variability of breathing in patients with restrictive lung disease. Am J Respir Crit Care Med. 2002;165:1260-1264.
144. Tenholder MF, Jones PA, Matthews JI, et al. Bullous emphysema. Progressive incremental exercise testing to evaluate candidates for bullectomy. Chest. 1980;77:802-805.
145. Teramoto S, Fukuchi Y, Nagase T, et al. Quantitative assessment of dyspnea during exercise before and after bullectomy for giant bulla. Chest. 1992;102:1362-1366.
146. Phipps B, Wong B, Chang CH, et al. Unexplained severe pulmonary hypertension in the older age group. Chest. 1983;84:399-402.
147. Braman SS, Eby E, Kuhn C, et al. Primary pulmonary hypertension in the elderly. Arch Intern Med. 1991;151:2433-2438.
148. Moser KM, Daily PO, Peterson K, et al. Thromboendarterectomy for chronic, major-vessel thromboembolic pulmonary hypertension. Immediate and long-term results in 42 patients. Ann Intern Med. 1987;107:560-565.
149. Benotti JR, Ockene IS, Alpert JS, et al. The clinical profile of unresolved pulmonary embolism. Chest. 1983;84:669-678.
150. Moser KM, Spragg RG, Utley J, et al. Chronic thrombotic obstruction of major pulmonary arteries. Results of thromboendarterectomy in 15 patients. Ann Intern Med. 1983;99:299-304.
151. Goldsmith SR, Dick C. Differentiating systolic from diastolic heart failure: pathophysiologic and therapeutic considerations. Am J Med. 1993;95:645-655.
152. Vasan RS, Benjamin EJ, Levy D. Congestive heart failure with normal left ventricular systolic function. Clinical approaches to the diagnosis and treatment of diastolic heart failure. Arch Intern Med. 1996;156:146-157.
153. Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann Intern Med. 1992;117:502-510.
154. Ilan Y, Oren R, Ben Chetrit E. Etiology, treatment, and prognosis of large pericardial effusions. A study of 34 patients. Chest. 1991;100:985-987.
155. Yokoyama H, Sato H, Hori M, et al. A characteristic change in ventilation mode during exertional dyspnea in patients with chronic heart failure. Chest. 1994;106:1007-1013.
156. Herlitz J, Brandrup-Wognsen G, Karlson BW, et al. Limitation of physical activity, dyspnoea and chest pain before and two years after coronary artery bypass grafting in relation to preoperative ejection fraction. Scand Cardiovasc J. 2000;34:65-72.
157. Davies SW. Clinical presentation and diagnosis of coronary artery disease: stable angina. Br Med Bull. 2001;59:17-27.
158. Krogh V, Trevisan M, Panico S, et al. Prevalence and correlates of angina pectoris in the Italian nine communities study. Research Group ATS-RF2 of the Italian National Research Council. Epidemiology. 1991;2:26-32.
159. Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure. Am J Cardiol. 1999;83:1A-38A.
160. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation. 1995;92:2764-2784.
161. Andersson B, Caidahl K, Waagstein F. An echocardiographic evaluation of patients with idiopathic heart failure. Chest. 1995;107:680-689.
162. Poppas A, Rounds S. Congestive heart failure. Am J Respir Crit Care Med. 2002;165:4-8.
163. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007-2018.
164. Caruana L, Petrie MC, Davie AP, et al. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from 'diastolic heart failure' or from misdiagnosis? A prospective descriptive study. BMJ. 2000;321:215-218.
165. Carabello BA. Clinical practice. Aortic stenosis. N Engl J Med. 2002;346:677-682.
166. Lombard JT, Selzer A. Valvular aortic stenosis. A clinical and hemodynamic profile of patients. Ann Intern Med. 1987;106:292-298.
167. Rahko PS. Prevalence of regurgitant murmurs in patients with valvular regurgitation detected by Doppler echocardiography. Ann Intern Med. 1989;111:466-472.
168. Schreiber TL, Fisher J, Mangla A, et al. Severe 'silent' mitral regurgitation. A potentially reversible cause of refractory heart failure. Chest. 1989;96:242-246.
169. Sherrid M, Goyal A, Delia E, et al. Unsuspected mitral stenosis. Am J Med. 1991;90:189-192.
170. Carabello BA, Crawford FA Jr. Valvular heart disease. N Engl J Med. 1997;337:32-41.
171. Sorrentino M, Resnekov L. Patent foramen ovale associated with platypnea and orthodeoxia. Chest. 1991;100:1157-1158.
172. Adolph EA, Lacy WO, Hermoni YI, et al. Reversible orthodeoxia and platypnea due to right-to-left intracardiac shunting related to pericardial effusion. Ann Intern Med. 1992;116:138-139.
173. Acebo E, Val-Bernal JF, Gomez-Roman JJ, et al. Clinicopathologic study and DNA analysis of 37 cardiac myxomas: a 28-year experience. Chest. 2003;123:1379-1385.
174. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. First of two parts. N Engl J Med. 2000;342:256-263.
175. Davies SF, McQuaid KR, Iber C, et al. Extreme dyspnea from unilateral pulmonary venous obstruction. Demonstration of a vagal mechanism and relief by right vagotomy. Am Rev Respir Dis. 1987;136:184-188.
176. Miller TD, Staats BA. Impaired exercise tolerance after inferior vena caval interruption. Chest. 1988;93:776-780.
177. Ben Dov I, Morag B, Farfel Z. Effect of venous obstruction of lower extremities on exercise tolerance. Chest. 1997;111:506-508.
178. O'Brien JD, Reiss CK. Pulmonary hypertension in a 45-year-old woman with recurrent deep venous thromboses. Chest. 1999;116:560-563.
179. Berry DF, Buccigrossi D, Peabody J, et al. Pulmonary vascular occlusion and fibrosing mediastinitis. Chest. 1986;89:296-301.
180. Auchincloss JH, Streeten DH, Gilbert R, et al. Dyspnea in patients with hyperbradykininism and excessive venous pooling. Am J Med. 1986;81:260-266.
181. Sahebjami H. Dyspnea in obese healthy men. Chest. 1998;114:1373-1377.
182. Ross R, Dagnone D, Jones PJ, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med. 2000;133:92-103.
183. Must A, Jacques PF, Dallal GE, et al. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992;327:1350-1355.
184. Weinsier RL, Hunter GR, Heini AF, et al. The etiology of obesity: relative contribution of metabolic factors, diet, and physical activity. Am J Med. 1998;105:145-150.
185. Bailey DA, Shephard RJ, Mirwald RL, et al. A current view of Canadian cardiorespiratory fitness. Can Med Assoc J. 1974;111:25-30.
186. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305-313.
187. Blankfield RP, Hudgel DW, Tapolyai AA, et al. Bilateral leg edema, obesity, pulmonary hypertension, and obstructive sleep apnea. Arch Intern Med. 2000;160:2357-2362.
188. Garcia-Rio F, Pino JM, Gomez L, et al. Regulation of breathing and perception of dyspnea in healthy pregnant women. Chest. 1996;110:446-453.
189. Gilbert R, Auchincloss JH Jr. Dyspnea of pregnancy. Clinical and physiological observations. Am J Med Sci. 1966;252:270-276.
190. Gilber R, Epler GR, Auchincloss JH. Dyspnea of pregnancy; a syndrome of altered respiratory control. JAMA. 1962;182:1073-1077.
191. Rizk NW, Kalassian KG, Gilligan T, et al. Obstetric complications in pulmonary and critical care medicine. Chest. 1996;110:791-809.
192. Smoller JW, Pollack MH, Otto MW, et al. Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. Am J Respir Crit Care Med. 1996;154:6-17.
193. Yu PN, Yim JB, Stanfield CA. Hyperventilation syndrome. Arch Intern Med. 1959:902-913.
194. Cowley DS, Roy-Byrne PP. Hyperventilation and panic disorder. Am J Med. 1987;83:929-937.
195. Wheatley CE. Hyperventilation syndrome: a frequent cause of chest pain. Chest. 1975;68:195-199.
196. Saisch SG, Wessely S, Gardner WN. Patients with acute hyperventilation presenting to an inner-city emergency department. Chest. 1996;110:952-957.
197. Goodwin RD, Pine DS. Respiratory disease and panic attacks among adults in the United States. Chest. 2002;122:645-650.
198. Burns BH, Howell JB. Disproportionately severe breathlessness in chronic bronchitis. Q J Med. 1969;38:277-294.
199. Wasserman K, Hansen JE, Sue DY, et al. Pathophysiology of disorders limiting exercise. Principles of Exercise Testing and Interpretation. 1999:95-114.
200. Small D, Gibbons W, Levy RD, et al. Exertional dyspnea and ventilation in hyperthyroidism. Chest. 1992;101:1268-1273.
201. Ayres J, Rees J, Clark TJ, et al. Thyrotoxicosis and dyspnoea. Clin Endocrinol (Oxf). 1982;16:65-71.
202. McElvaney GN, Wilcox PG, Fairbarn MS, et al. Respiratory muscle weakness and dyspnea in thyrotoxic patients. Am Rev Respir Dis. 1990;141:1221-1227.
203. Weiss DJ, Kreck T, Albert RK. Dyspnea resulting from fibromyalgia. Chest. 1998;113:246-249.
204. De Becker P, Roeykens J, Reynders M, et al. Exercise capacity in chronic fatigue syndrome. Arch Intern Med. 2000;160:3270-3277.
205. Reuben DB, Mor V. Dyspnea in terminally ill cancer patients. Chest. 1986;89:234-236.
206. Silvestri GA, Sherman C, Williams T, et al. Caring for the dying patient with lung cancer. Chest. 2002;122:1028-1036.
207. Booth S, Kelly MJ, Cox NP, et al. Does oxygen help dyspnea in patients with cancer? Am J Respir Crit Care Med. 1996;153:1515-1518.
208. Diaz PT, Wewers MD, Pacht E, et al. Respiratory symptoms among HIV-seropositive individuals. Chest. 2003;123:1977-1982.
209. Bellia V, Battaglia S, Catalano F, et al. Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. Chest. 2003;123:1066-1072.
210. Elliott MW, Adams L, Cockcroft A, et al. The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. Am Rev Respir Dis. 1991;144:826-832.
211. King DK, Thompson BT, Johnson DC. Wheezing on maximal forced exhalation in the diagnosis of atypical asthma. Lack of sensitivity and specificity. Ann Intern Med. 1989;110:451-455.
212. Piirila P, Sovijarvi AR, Kaisla T, et al. Crackles in patients with fibrosing alveolitis, bronchiectasis, COPD, and heart failure. Chest. 1991;99:1076-1083.
213. Zema MJ, Masters AP, Margouleff D. Dyspnea: the heart or the lungs? Differentiation at bedside by use of the simple Valsalva maneuver. Chest. 1984;85:59-64.
214. Weilenmann D, Rickli H, Follath F, et al. Noninvasive evaluation of pulmonary capillary wedge pressure by BP response to the Valsalva maneuver. Chest. 2002;122:140-145.
215. Stevenson LW, Perloff JK. The limited reliability of physical signs for
216. Badgett RG, Lucey CR, Mulrow CD. Can the clinical examination diagnose left-sided heart failure in adults? JAMA. 1997;277:1712-1719.
217. Chetty KG, Brown SE, Light RW. Identification of pulmonary hypertension in chronic obstructive pulmonary disease from routine chest radiographs. Am Rev Respir Dis. 1982;126:338-341.
218. Mahler DA, Horowitz MB. Clinical evaluation of exertional dyspnea. Clin Chest Med. 1994;15:259-269.
219. Muller NL, Miller RR. Computed tomography of chronic diffuse infiltrative lung disease. Part 2. Am Rev Respir Dis. 1990;142:1440-1448.
220. Gelb AF, Tashkin DP, Epstein JD, et al. Physiologic characteristics of malignant unilateral main-stem bronchial obstruction. Diagnosis and Nd-YAG laser treatment. Am Rev Respir Dis. 1988;138:1382-1385.
221. Monkare S, Ikonen M, Haahtela T. Radiologic findings in farmer's lung. Prognosis and correlation to lung function. Chest. 1985;87:460-466.
222. Knudson RJ, Standen JR, Kaltenborn WT, et al. Expiratory computed tomography for assessment of suspected pulmonary emphysema. Chest. 1991;99:1357-1366.
223. Orens JB, Kazerooni EA, Martinez FJ, et al. The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy. A prospective study. Chest. 1995;108:109-115.
224. van Strijen MJ, de Monye W, Schiereck J, et al. Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: a multicenter clinical management study of 510 patients. Ann Intern Med. 2003;138:307-314.
225. Adelroth E, Hargreave FE, Ramsdale EH. Do physicians need objective measurements to diagnose asthma? Am Rev Respir Dis. 1986;134:704-707.
226. Joyce DP, Chapman KR, Kesten S. Prior diagnosis and treatment of patients with normal results of methacholine challenge and unexplained respiratory symptoms. Chest. 1996;109:697-701.
227. Perkins PJ, Morris MJ. Vocal cord dysfunction induced by methacholine challenge testing. Chest. 2002;122:1988-1993.
228. Kesten S, Rebuck AS. Is the short-term response to inhaled beta-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD? Chest. 1994;105:1042-1045.
229. ten Brinke A, Zwinderman AH, Sterk PJ, et al. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med. 2001;164:744-748.
230. Acres JC, Kryger MH. Clinical significance of pulmonary function tests: upper airway obstruction. Chest. 1981;80:207-211.
231. Johnson BD, Beck KC, Olson LJ, et al. Pulmonary function in patients with reduced left ventricular function: influence of smoking and cardiac surgery. Chest. 2001;120:1869-1876.
232. Siegel JL, Miller A, Brown LK, et al. Pulmonary diffusing capacity in left ventricular dysfunction. Chest. 1990;98:550-553.
233. Nadel JA, Gold WM, Burgess JH. Early diagnosis of chronic pulmonary vascular obstruction; value of pulmonary function tests. Am J Med. 1968;44:16-25.
234. Otto CM. Clinical practice. Evaluation and management of chronic mitral regurgitation. N Engl J Med. 2001;345:740-746.
235. Bossone E, Avelar E, Bach DS, et al. Diagnostic value of resting tricuspid regurgitation velocity and right ventricular ejection flow parameters for the detection of exercise induced pulmonary arterial hypertension. Int J Card Imaging. 2000;16:429-436.
236. Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med. 2003;167:735-740.
237. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211-277.
238. Mohnssen SR, Weisman IM, Zeballos RJ, et al. Heart or lung disease: determining the primary cause for dyspnea on exertion. Chest. 1998;113:1705-1710.
239. Becklake MR. Organic or functional impairment. Overall perspective. Am Rev Respir Dis. 1984;129:S96-100.
240. Wasserman K. Dyspnea on exertion. Is it the heart or the lungs? JAMA. 1982;248:2039-2043.
241. Sue DY, Wasserman K. Impact of integrative cardiopulmonary exercise testing on clinical decision making. Chest. 1991;99:981-992.
242. Messner-Pellenc P, Ximenes C, Brasileiro CF, et al. Cardiopulmonary exercise testing. Determinants of dyspnea due to cardiac or pulmonary limitation. Chest. 1994;106:354-360.
243. Gallagher CG, Younes M. Breathing pattern during and after maximal exercise in patients with chronic obstructive lung disease, interstitial lung disease, and cardiac disease, and in normal subjects. Am Rev Respir Dis. 1986;133:581-586.
244. Eschenbacher WL, Mannina A. An algorithm for the interpretation of cardiopulmonary exercise tests. Chest. 1990;97:263-267.
245. Hamilton AL, Killian KJ, Summers E, et al. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med. 1995;152:2021-2031.
246. McParland C, Krishnan B, Wang Y, et al. Inspiratory muscle weakness and dyspnea in chronic heart failure. Am Rev Respir Dis. 1992;146:467-472.
247. Hughes PD, Hart N, Hamnegard CH, et al. Inspiratory muscle relaxation rate slows during exhaustive treadmill walking in patients with chronic heart failure. Am J Respir Crit Care Med. 2001;163:1400-1403.
248. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211-277.
249. D'Alonzo GE, Gianotti LA, Pohil RL, et al. Comparison of progressive exercise performance of normal subjects and patients with primary pulmonary hypertension. Chest. 1987;92:57-62.
250. D'Alonzo GE, Bower JS, Dantzker DR. Differentiation of patients with primary and thromboembolic pulmonary hypertension. Chest. 1984;85:457-461.
251. Lewczuk J, Piszko P, Jagas J, et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest. 2001;119:818-823.
252. Rubin LJ. Approach to the diagnosis and treatment of pulmonary hypertension. Chest. 1989;96:659-664.
253. Kruger S, Haage P, Hoffmann R, et al. Diagnosis of pulmonary arterial hypertension and pulmonary embolism with magnetic resonance angiography. Chest. 2001;120:1556-1561.
254. Silverman JM, Julien PJ, Herfkens RJ, et al. Magnetic resonance imaging evaluation of pulmonary vascular malformations. Chest. 1994;106:1333-1338.
255. Khalil A, Farres MT, Mangiapan G, et al. Pulmonary arteriovenous malformations. Chest. 2000;117:1399-1403.
256. Morrison LK, Harrison A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol. 2002;39:202-209.
257. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
258. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647-654.
259. Cabanes L, Richaud-Thiriez B, Fulla Y, et al. Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea. Chest. 2001;120:2047-2050.
260. Chatterjee K. Primary diastolic heart failure. Am J Geriatr Cardiol. 2002;11:178-187.
261. McFadden ER Jr, Zawadski DK. Vocal cord dysfunction masquerading as exercise-induced asthma. a physiologic cause for 'choking' during athletic activities. Am J Respir Crit Care Med. 1996;153:942-947.
262. Shorr AF, Torrington KG, Hnatiuk OW. Endobronchial biopsy for sarcoidosis: a prospective study. Chest. 2001;120:109-114.
263. Levy H, Horak DA, Lewis MI. The value of bronchial washings and bronchoalveolar lavage in the diagnosis of lymphangitic carcinomatosis. Chest. 1988;94:1028-1030.
264. Rubin LJ. Primary pulmonary hypertension. N Engl J Med. 1997;336:111-117.
265. Weisman IM, Zeballos RJ. Clinical evaluation of unexplained dyspnea. Cardiologia. 1996;41:621-634.
266. Weisman IM, Zeballos RJ. A step approach to the evaluation of unexplained dyspnea: the role of cardiopulmonary exercise testing. Pulmonary Perspectives. 1998:8-11.
267. Palevsky HI, Pietra GG, Fishman AP. Pulmonary veno-occlusive disease and its response to vasodilator agents. Am Rev Respir Dis. 1990;142:426-429.
268. Mandel J, Mark EJ, Hales CA. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med. 2000;162:1964-1973.
269. Holcomb BW, Jr., Loyd JE, Ely EW, et al. Pulmonary veno-occlusive disease: a case series and new observations. Chest. 2000;118:1671-1679.
270. Kerr KM, Auger WR, Fedullo PF, et al. Large vessel pulmonary artcritis mimicking chronic thromboembolic disease. Am J Respir Crit Care Med. 1995;152:367-373.
271. Taylor BG, Cockerill EM, Manfredi F, et al. Therapeutic embolization of the pulmonary artery in pulmonary arteriovenous fistula. Am J Med. 1978;64:360-365.
272. Dansky HM, Schwinger ME, Cohen MV. Using contrast material-enhanced echocardiography to identify abnormal pulmonary arteriovenous connections in patients with hypoxemia. Chest. 1992;102:1690-1692.
273. Gottlieb LS, Turner AF. Swyer-James (Macleod's) syndrome. Variations in pulmonary-bronchial arterial blood flow. Chest. 1976;69:62-66.
274. Gossage JR, Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med. 1998;158:643-661.
275. Budhiraja R, Hassoun PM. Portopulmonary hypertension: a tale of two circulations. Chest. 2003;123:562-576.
276. Watanabe S, Shimokawa S, Sakasegawa K, et al. Choriocarcinoma in the pulmonary artery treated with emergency pulmonary embolectomy. Chest. 2002;121:654-656.
277. Brassard JM, Johnson JE. Unilateral absence of a pulmonary artery. Data from cardiopulmonary exercise testing. Chest. 1993;103:293-295.
278. Parish JM, Rosenow EC, III, Swensen SJ, et al. Pulmonary artery sarcoma. Clinical features. Chest. 1996;110:1480-1488.
279. Kane RD, Hawkins HK, Miller JA, et al. Microscopic pulmonary tumor emboli associated with dyspnea. Cancer. 1975;36:1473-1482.
280. Bassiri AG, Haghighi B, Doyle RL, et al. Pulmonary tumor embolism. Am J Respir Crit Care Med. 1997;155:2089-2095.
281. Yang SP, Lin CC. Lymphangitic carcinomatosis of the lungs. The clinical significance of its roentgenologic classification. Chest. 1972;62:179-187.
282. Filderman AE. Malignancies metastatic to the lung. Clin Pulm Med. 1994;1:116-128.